Balyasny Asset Management LLC Meridian Bioscience Inc Call Options Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VIVO
# of Institutions
10Shares Held
113KCall Options Held
0Put Options Held
0-
Havens Advisors LLC New York, NY26.8KShares$02.29% of portfolio
-
Telemetry Investments, L.L.C. New York, NY20.3KShares$01.06% of portfolio
-
Advisor Partners LLC Walnut Creek, CA19.7KShares$00.04% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA18.3KShares$00.59% of portfolio
-
Brinker Capital Investments, LLC16KShares$00.01% of portfolio
About MERIDIAN BIOSCIENCE INC
- Ticker VIVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 43,748,000
- Description
- Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...